MCLE OTC
Medicale Corp
1W: -0.0%
1M: +100.0%
3M: -98.4%
YTD: -98.5%
1Y: -99.7%
3Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$33K
+38.8% ▲
Net Income
-$41K
+29.3% ▲
EPS (Diluted)
$-0.01
+28.6% ▲
EBITDA
-$33K
+0.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $2K | $2K | $0 | $0 | $0 |
| Gross Profit | -$2K | -$2K | $0 | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $32K | $44K | $38K | $55K | $0 |
| Operating Expenses | $32K | $44K | $38K | $55K | $33K |
| Operating Income | -$32K | -$44K | -$38K | -$55K | -$33K |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $0 | $0 | $0 | $4K | $8K |
| Income Before Tax | -$32K | -$44K | -$38K | -$58K | -$41K |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$32K | -$46K | -$37K | -$58K | -$41K |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.01 | $-0.01 | $-0.01 | $-0.01 | $-0.01 |
| EBITDA | -$30K | -$42K | $0 | $0 | -$33K |
| Shares Outstanding | 6M | 6M | 6M | 6M | 6M |